We are live on ! Find out more

599 hedge funds and large institutions have $5.86B invested in Haleon in 2025 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 193 increasing their positions, 206 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $1.28M | Put options by funds: $389K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

4% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 55

6% less repeat investments, than reductions

Existing positions increased: 193 | Existing positions reduced: 206

2% less funds holding

Funds holding: 610599 (-11)

1.8% less ownership

Funds ownership: 8.11%6.31% (-1.8%)

16% less capital invested

Capital invested by funds: $7.01B → $5.86B (-$1.15B)

Holders
599
Holders Change
-11
Holders Change %
-1.8%
% of All Funds
8.02%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
53
Increased
193
Reduced
206
Closed
55
Calls
$1.28M
Puts
$389K
Net Calls
+$891K
Net Calls Change
-$1.87M

HLN Hedge Fund Activity: Q1 2025 in Review

599 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Haleon (HLN) for Q1 2025, worth a combined $5.86B — down 16% from $7.01B a quarter earlier.

Sellers outnumbered buyers: 55 funds closed out of HLN and 53 opened new positions — a net loss of 2 holders — while 206 trimmed existing stakes and 193 added.

The largest buyer was Altshuler Shaham, adding an estimated $76.8M. The largest seller was Pfizer, exiting entirely with an estimated $1.88B sold.

  • 599 institutional investors held Haleon (HLN) as of Q1 2025, down from 610 in Q4 2024.
  • Funds reported $5.86B of Haleon stock for Q1 2025, down 16% quarter-over-quarter.
  • 53 funds opened new Haleon positions in Q1 2025 and 55 closed out, a net change of -2 holders.
  • The largest Haleon buyer in Q1 2025 was Altshuler Shaham, an estimated $76.8M added.
  • The largest Haleon seller in Q1 2025 was Pfizer, an estimated $1.88B sold.

Based on aggregated 13F filings for Q1 2025.